olaparib,bevacizumab
merck,astrazeneca,roche
['olaparib', 'ovarian', 'gyn']
 i have been doing parpi+ bev as per paola trial in that population. challenge is that we don t have data for bev+olaparib versus olaparib alone. very needed. #ovariancancer #gyncsm #asco22
Breast & gyn med onc @valleyhospital in NJ. Focus on survivorship and ?????? onc. All opinions my own. Retweets not endorsements. Host of INTERLUDE podcast ??